The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease
Yanqi Qi,* Jiawen Xu,* Zhe Lin,* Yijing Tao, Fenglei Zheng, Yujia Wang, Yameng Sun, Songling Fu, Wei Wang, Chunhong Xie, Yiying Zhang, Fangqi Gong Department of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Chil...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c75fce8f2184429ca7325c8a43feb069 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c75fce8f2184429ca7325c8a43feb069 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c75fce8f2184429ca7325c8a43feb0692021-11-21T19:08:51ZThe Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease1178-7031https://doaj.org/article/c75fce8f2184429ca7325c8a43feb0692021-11-01T00:00:00Zhttps://www.dovepress.com/the-network-of-pro-inflammatory-factors-cd147-dcr3-and-il33-in-the-dev-peer-reviewed-fulltext-article-JIRhttps://doaj.org/toc/1178-7031Yanqi Qi,* Jiawen Xu,* Zhe Lin,* Yijing Tao, Fenglei Zheng, Yujia Wang, Yameng Sun, Songling Fu, Wei Wang, Chunhong Xie, Yiying Zhang, Fangqi Gong Department of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310052, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fangqi GongDepartment of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People’s Republic of ChinaTel/Fax +86-571-88873008Email gongfangqi@zju.edu.cnIntroduction: Kawasaki disease (KD) is an acute febrile systemic vasculitis, but the etiology remains unknown. We studied serum levels of CD147, DcR3, and IL33 in different stages of KD to explore the value of CD147, DcR3, and IL33 in the pathophysiology of KD.Methods: We measured serum levels of CD147, DcR3, and IL33 by enzyme-linked immunosorbent assay (ELISA) at different stages with 71 KD patients and 66 healthy control children. We apply for network tools GeneMANIA and Cytoscape APP to analyze the functions of these pro-inflammatory factors at the gene and protein level.Results: Serum levels of CD147, DcR3, and IL33 were significantly increased in KD patients before IVIG treatment. Serum levels of CD147, DcR3, and IL33 gradually decreased over time after the treatment of IVIG. Eight cases were IVIG non-responders, while nine KD patients got CALs, but they did not overlap. And there were no statistical differences between group IVIG responders and IVIG non-responders or between groups without CALs and with CALs. We explored the functions of CD147, DcR3, and IL33 from GeneMANIA and Cytoscape APP and found these third pro-inflammatory factors were coexpressed, physical interactions, genetic interactions with other KD-related factors.Conclusion: CD147, DcR3, and IL33 are involved in the pathophysiology of KD, which provides novel evidence for diagnosing and treating KD with their inhibitors.Keywords: Kawasaki disease, coronary artery lesions, CD147, DcR3, IL33, PI3K/AKT pathwayQi YXu JLin ZTao YZheng FWang YSun YFu SWang WXie CZhang YGong FDove Medical Pressarticlekawasaki diseasecoronary artery lesionscd147dcr3il33pi3k/akt pathwayPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 6043-6053 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
kawasaki disease coronary artery lesions cd147 dcr3 il33 pi3k/akt pathway Pathology RB1-214 Therapeutics. Pharmacology RM1-950 |
spellingShingle |
kawasaki disease coronary artery lesions cd147 dcr3 il33 pi3k/akt pathway Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Qi Y Xu J Lin Z Tao Y Zheng F Wang Y Sun Y Fu S Wang W Xie C Zhang Y Gong F The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease |
description |
Yanqi Qi,* Jiawen Xu,* Zhe Lin,* Yijing Tao, Fenglei Zheng, Yujia Wang, Yameng Sun, Songling Fu, Wei Wang, Chunhong Xie, Yiying Zhang, Fangqi Gong Department of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310052, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fangqi GongDepartment of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Hangzhou, 310052, People’s Republic of ChinaTel/Fax +86-571-88873008Email gongfangqi@zju.edu.cnIntroduction: Kawasaki disease (KD) is an acute febrile systemic vasculitis, but the etiology remains unknown. We studied serum levels of CD147, DcR3, and IL33 in different stages of KD to explore the value of CD147, DcR3, and IL33 in the pathophysiology of KD.Methods: We measured serum levels of CD147, DcR3, and IL33 by enzyme-linked immunosorbent assay (ELISA) at different stages with 71 KD patients and 66 healthy control children. We apply for network tools GeneMANIA and Cytoscape APP to analyze the functions of these pro-inflammatory factors at the gene and protein level.Results: Serum levels of CD147, DcR3, and IL33 were significantly increased in KD patients before IVIG treatment. Serum levels of CD147, DcR3, and IL33 gradually decreased over time after the treatment of IVIG. Eight cases were IVIG non-responders, while nine KD patients got CALs, but they did not overlap. And there were no statistical differences between group IVIG responders and IVIG non-responders or between groups without CALs and with CALs. We explored the functions of CD147, DcR3, and IL33 from GeneMANIA and Cytoscape APP and found these third pro-inflammatory factors were coexpressed, physical interactions, genetic interactions with other KD-related factors.Conclusion: CD147, DcR3, and IL33 are involved in the pathophysiology of KD, which provides novel evidence for diagnosing and treating KD with their inhibitors.Keywords: Kawasaki disease, coronary artery lesions, CD147, DcR3, IL33, PI3K/AKT pathway |
format |
article |
author |
Qi Y Xu J Lin Z Tao Y Zheng F Wang Y Sun Y Fu S Wang W Xie C Zhang Y Gong F |
author_facet |
Qi Y Xu J Lin Z Tao Y Zheng F Wang Y Sun Y Fu S Wang W Xie C Zhang Y Gong F |
author_sort |
Qi Y |
title |
The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease |
title_short |
The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease |
title_full |
The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease |
title_fullStr |
The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease |
title_full_unstemmed |
The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease |
title_sort |
network of pro-inflammatory factors cd147, dcr3, and il33 in the development of kawasaki disease |
publisher |
Dove Medical Press |
publishDate |
2021 |
url |
https://doaj.org/article/c75fce8f2184429ca7325c8a43feb069 |
work_keys_str_mv |
AT qiy thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT xuj thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT linz thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT taoy thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT zhengf thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT wangy thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT suny thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT fus thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT wangw thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT xiec thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT zhangy thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT gongf thenetworkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT qiy networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT xuj networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT linz networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT taoy networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT zhengf networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT wangy networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT suny networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT fus networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT wangw networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT xiec networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT zhangy networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease AT gongf networkofproinflammatoryfactorscd147dcr3andil33inthedevelopmentofkawasakidisease |
_version_ |
1718418727426326528 |